A GUIDE TO SUSTAINABLE PHARMACEUTICALS

This guide provides a practical, science-based introduction to the impacts that matter most, the commercial and regulatory forces driving action, and the steps organisations can take to create credible progress across sites, suppliers and product portfolios. It is relevant to pharmaceutical manufacturers, marketing authorisation holders, virtual and generics businesses, contract manufacturers, API producers, laboratories and organisations supplying medicines to the NHS and wider public sector.

Fill out the form to receive your copy today.

WHAT'S INCLUDED INSIDE

It will help you to:

Identify material carbon, energy, water, waste, pollution, biodiversity and resource impacts across pharmaceutical value chains.
Navigate compliance requirements and expectations, including PAS 2090, PPN 006, the NHS Net Zero Supplier Roadmap, Evergreen, packaging EPR and environmental claims.
Build an organisational carbon baseline and a credible, investable reduction plan while working within GMP and change control constraints.
Use pharmaceutical Life Cycle Assessment (LCA) and product carbon footprinting to understand impacts from API production through patient use and end-of-life.
Improve Scope 3 data and supplier engagement across API, excipient, packaging, device, logistics and contract manufacturing partners.
Prioritise actions that support resilience, tender readiness, operational efficiency and defensible sustainability communication.

Guide to Pharmaceuticals - Cover - Small

OUR SERVICES

Looking for additional support? Take a look through our areas of expertise and get in touch to see how we can help your organisation reach their carbon, nature, water or compliance goals.

TOUCH